Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, C.-Q.
Right arrow Articles by Wogan, G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, C.-Q.
Right arrow Articles by Wogan, G. N.
[Cancer Research 64, 3022-3029, May 1, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Apoptotic Signaling Pathways Induced by Nitric Oxide in Human Lymphoblastoid Cells Expressing Wild-Type or Mutant p53

Chun-Qi Li1, Ana I. Robles2, Christin L. Hanigan2, Lorne J. Hofseth2, Laura J. Trudel1, Curtis C. Harris2 and Gerald N. Wogan1,2

1 Biological Engineering Division and Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts; and 2 Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland

Loss of p53 function by inactivating mutations results in abrogation of NO·-induced apoptosis in human lymphoblastoid cells. Here we report characterization of apoptotic signaling pathways activated by NO· in these cells by cDNA microarray expression and immunoblotting. A p53-mediated transcriptional response to NO· was observed in p53-wild-type TK6, but not in closely related p53-mutant WTK1, cells. Several previously characterized p53 target genes were up-regulated transcriptionally in TK6 cells, including phosphatase PPM1D (WIP1), oxidoreductase homolog PIG3, death receptor TNFRSF6 (Fas/CD95), and BH3-only proteins BBC3 (PUMA) and PMAIP1 (NOXA). NO· also modulated levels of several gene products in the mitochondria-dependent and death-receptor-mediated apoptotic pathways. Inhibitors of apoptosis proteins X-chromosome-linked inhibitor of apoptosis, cellular inhibitor of apoptosis protein-1, and survivin were significantly down-regulated in TK6 cells, but not in WTK1 cells. Smac release from mitochondria was induced in both cell types, but release of apoptosis-inducing factor and endonuclease G was detected only in TK6 cells. Fas/CD95 was increased, and levels of the antiapoptotic proteins Bcl-2 and Bcl-x/L were reduced in TK6 cells. Activation of procaspases 3, 8, 9, and 10, as well as Bid and poly(ADP-ribose) polymerase cleavage, were observed only in TK6 cells. NO· treatment did not alter levels of death receptors 4 and 5, Fas-associated death domain or proapoptotic Bax and Bak proteins in either cell line. Collectively, these data show that NO· exposure activated a complex network of responses leading to p53-dependent apoptosis via both mitochondrial and Fas receptor pathways, which were abrogated in the presence of mutant p53.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
S. Dhakshinamoorthy, S. R. Sridharan, L. Li, P. Y. Ng, L. M. Boxer, and A. G. Porter
Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability
Nucleic Acids Res., August 15, 2007; (2007) gkm594v1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Azad, V. Vallyathan, L. Wang, V. Tantishaiyakul, C. Stehlik, S. S. Leonard, and Y. Rojanasakul
S-Nitrosylation of Bcl-2 Inhibits Its Ubiquitin-Proteasomal Degradation: A NOVEL ANTIAPOPTOTIC MECHANISM THAT SUPPRESSES APOPTOSIS
J. Biol. Chem., November 10, 2006; 281(45): 34124 - 34134.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. v. Brocke, H. H. Schmeiser, M. Reinbold, and M. Hollstein
MEF immortalization to investigate the ins and outs of mutagenesis
Carcinogenesis, November 1, 2006; 27(11): 2141 - 2147.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Su, J. Kuball, A.-P. Barreiros, D. Gottfried, E. A. Ferreira, M. Theobald, P. R. Galle, D. Strand, and S. Strand
Nitric Oxide Promotes Resistance to Tumor Suppression by CTLs
J. Immunol., April 1, 2006; 176(7): 3923 - 3930.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Yang, M. Fraser, U. M. Moll, A. Basak, and B. K. Tsang
Akt-Mediated Cisplatin Resistance in Ovarian Cancer: Modulation of p53 Action on Caspase-Dependent Mitochondrial Death Pathway.
Cancer Res., March 15, 2006; 66(6): 3126 - 3136.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Chanvorachote, U. Nimmannit, L. Wang, C. Stehlik, B. Lu, N. Azad, and Y. Rojanasakul
Nitric Oxide Negatively Regulates Fas CD95-induced Apoptosis through Inhibition of Ubiquitin-Proteasome-mediated Degradation of FLICE Inhibitory Protein
J. Biol. Chem., December 23, 2005; 280(51): 42044 - 42050.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Staib, A. I. Robles, L. Varticovski, X. W. Wang, B. R. Zeeberg, M. Sirotin, V. B. Zhurkin, L. J. Hofseth, S. P. Hussain, J. N. Weinstein, et al.
The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress
Cancer Res., November 15, 2005; 65(22): 10255 - 10264.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. M. McLaughlin and B. Demple
Nitric Oxide-Induced Apoptosis in Lymphoblastoid and Fibroblast Cells Dependent on the Phosphorylation and Activation of p53
Cancer Res., July 15, 2005; 65(14): 6097 - 6104.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.